Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Fatigue 6 Breast Neoplasms 5 Anxiety Disorders 3 Psychological Well-Being 2 Pain 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Depression 2 Caregiver Burden 2 Uterine Neoplasms 1 Tuberous Sclerosis 1 Substance-Related Disorders 1 Smoking Cessation 1 Sleep Wake Disorders 1 Sleep Initiation and Maintenance Disorders 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Ovarian Neoplasms 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasm Regression, Spontaneous 1 Multiple Myeloma 1 Malignant Hepatobiliary Neoplasm 1 Lymphoma 1 Leukemia 1 Hematopoietic Cell Transplantation Recipient 1 Head and Neck Neoplasms 1

Interventions

Temozolomide 162 Radiosurgery 115 Radiotherapy 100 Bevacizumab 96 Magnetic Resonance Spectroscopy 65 Carboplatin 48 Etoposide 34 pembrolizumab 33 Surgical Procedures, Operative 33 Irinotecan 33 Nivolumab 32 Cyclophosphamide 32 Erlotinib Hydrochloride 31 Radiation 30 Carmustine 28 Lomustine 25 Cisplatin 25 Trastuzumab 23 Ipilimumab 23 Filgrastim 23 Vincristine 20 Mental Status and Dementia Tests 20 Aminolevulinic Acid 19 Topotecan 18 Pemetrexed 18 Capecitabine 18 Specimen Handling 17 Sorafenib 15 Radiotherapy, Intensity-Modulated 15 Imatinib Mesylate 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brain Neoplasms × Acceptance and Commitment Therapy × Clear all

NCT04722237 2023-08-31

ACT NOW

Nottingham University Hospitals NHS Trust

Phase NA Unknown

Brain Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡